Perineural ondansetron
PreclinicalSmall molecule
Perineural ondansetron is one of 8 small molecule programs targeting Laparoscopic Sleeve Gastrectomy. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Laparoscopic Sleeve Gastrectomy
#DrugCompanyPhaseTrials
1Lioresal
NovartisPhase 3
Neurontin
VViatris Specialty LLC
Phase 3
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Phase 2
Reglan
IIstituto Clinico Humanitas
Preclinical
Chirocaine
PPurdue Pharma LP
Preclinical
Adrenaline
AARS Pharmaceuticals, Inc.
Preclinical
Esketamine Hydrochloride
TThe Second Hospital of Anhui Medical University
Preclinical
Perineural ondansetron
TTanta University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Perineural ondansetron. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- TTanta University